Evolution of CRISPR/Cas Systems for Precise Genome Editing
cris.virtual.author-orcid | 0000-0002-1496-1502 | |
cris.virtual.author-orcid | 0000-0002-0199-9245 | |
cris.virtual.author-orcid | 0000-0002-1208-3291 | |
cris.virtualsource.author-orcid | a706896c-13b8-4acd-8e84-35ef99d53321 | |
cris.virtualsource.author-orcid | 5a42524e-79b2-4abc-87a0-36571ec9f87a | |
cris.virtualsource.author-orcid | 0e52860c-9c5d-441c-b9ad-689938b2c236 | |
dc.abstract.en | The bacteria-derived CRISPR/Cas (an acronym for regularly interspaced short palindromic repeats/CRISPR-associated protein) system is currently the most widely used, versatile, and convenient tool for genome engineering. CRISPR/Cas-based technologies have been applied to disease modeling, gene therapies, transcriptional modulation, and diagnostics. Nevertheless, some challenges remain, such as the risk of immunological reactions or off-target effects. To overcome these problems, many new methods and CRISPR/Cas-based tools have been developed. In this review, we describe the current classification of CRISPR systems and new precise genome-editing technologies, summarize the latest applications of this technique in several fields of research, and, finally, discuss CRISPR/Cas system limitations, ethical issues, and challenges. | |
dc.affiliation | Wydział Rolnictwa, Ogrodnictwa i Biotechnologii | |
dc.affiliation.institute | Katedra Biochemii i Biotechnologii | |
dc.contributor.author | Hryhorowicz, Magdalena Julita | |
dc.contributor.author | Lipiński, Daniel | |
dc.contributor.author | Zeyland, Joanna | |
dc.date.access | 2025-02-25 | |
dc.date.accessioned | 2025-02-25T12:11:06Z | |
dc.date.available | 2025-02-25T12:11:06Z | |
dc.date.copyright | 2023-09-18 | |
dc.date.issued | 2023 | |
dc.description.abstract | <jats:p>The bacteria-derived CRISPR/Cas (an acronym for regularly interspaced short palindromic repeats/CRISPR-associated protein) system is currently the most widely used, versatile, and convenient tool for genome engineering. CRISPR/Cas-based technologies have been applied to disease modeling, gene therapies, transcriptional modulation, and diagnostics. Nevertheless, some challenges remain, such as the risk of immunological reactions or off-target effects. To overcome these problems, many new methods and CRISPR/Cas-based tools have been developed. In this review, we describe the current classification of CRISPR systems and new precise genome-editing technologies, summarize the latest applications of this technique in several fields of research, and, finally, discuss CRISPR/Cas system limitations, ethical issues, and challenges.</jats:p> | |
dc.description.accesstime | at_publication | |
dc.description.bibliography | il., bibliogr. | |
dc.description.finance | publication_nocost | |
dc.description.financecost | 0,00 | |
dc.description.if | 4,9 | |
dc.description.number | 18 | |
dc.description.points | 140 | |
dc.description.review | review | |
dc.description.version | final_published | |
dc.description.volume | 24 | |
dc.identifier.doi | 10.3390/ijms241814233 | |
dc.identifier.issn | 1422-0067 | |
dc.identifier.uri | https://sciencerep.up.poznan.pl/handle/item/2510 | |
dc.identifier.weblink | https://www.mdpi.com/1422-0067/24/18/14233 | |
dc.language | en | |
dc.pbn.affiliation | biotechnology | |
dc.pbn.affiliation | agriculture and horticulture | |
dc.relation.ispartof | International Journal of Molecular Sciences | |
dc.relation.pages | art. 14233 | |
dc.rights | CC-BY | |
dc.sciencecloud | nosend | |
dc.subject.en | CRISPR/Cas9 system | |
dc.subject.en | CRISPR classification | |
dc.subject.en | Cas9 nuclease | |
dc.subject.en | Cas12a nuclease | |
dc.subject.en | Cas13a nuclease | |
dc.subject.en | genome editing | |
dc.subject.en | base editors | |
dc.subject.en | prime editors | |
dc.title | Evolution of CRISPR/Cas Systems for Precise Genome Editing | |
dc.title.volume | Special Issue CRISPR-Cas Systems and Genome Editing | |
dc.type | JournalArticle | |
dspace.entity.type | Publication | |
oaire.citation.issue | 18 | |
oaire.citation.volume | 24 |